CK2α Deficiency Drives Myocardial Fibrosis via Desmin‐Induced Mitochondrial Dysfunction
Advanced Science · 2026
DOI: 10.1002/advs.75560 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Canjie Ma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Key Laboratory of Genome Stability and Human Disease Prevention, Carson International Cancer Center, Shenzhen Key Laboratory of Anti-Aging …. Hauptthemen laut MEDLINE: Casein Kinase II, Myocytes, Cardiac, Fibrosis, Desmin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project of the Ministry of Science and Technology of China, National Key R&D Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Myocardial fibrosis, a hallmark of heart failure, is driven by pathological crosstalk between stressed cardiomyocytes and activated fibroblasts, yet the initiating signals from cardiomyocytes remain poorly defined. Here, we identify downregulation of casein kinase 2α (CK2α) in cardiomyocytes as a conserved and early trigger of fibrotic remodeling. Cardiomyocyte‐specific CK2α loss induces progressive mitochondrial proteome collapse, metabolic reprogramming, and bioenergetic failure. This mitochondrial impairment induces oxidative stress and sterile inflammation, subsequently activating cardiac fibroblasts via paracrine mediators, such as IL‐6, thereby establishing a direct mechanistic link between a cardiomyocyte‐intrinsic defect and fibroblast activation. Mechanistically, CK2α preserves mitochondrial‐cytoskeletal integrity by directly phosphorylating the intermediate filament Desmin at threonine 452 (Thr452). This phosphorylation recruits the chaperone protein αB‐crystallin (Cryab) to prevent pathological Desmin aggregation. Disruption of this quality control checkpoint, suffices to recapitulate the full spectrum of mitochondrial dysfunction and pro‐fibrotic signaling. Notably, AAV9‐mediated restoration of CK2α specifically in cardiomyocytes preserves mitochondrial structure, rescues bioenergetic function, and attenuates fibrosis. Our findings uncover a CK2α–Desmin–mitochondrial quality control axis as a critical metabolic‐structural checkpoint in cardiomyocytes and establish that cardiomyocyte‐initiated paracrine signaling drives fibroblast activation, highlighting new therapeutic strategies for fibrotic heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Key Laboratory of Genome Stability and Human Disease Prevention, Carson International Cancer Center, Shenzhen Key Laboratory of Anti-Aging and Regenerative Medicine (SKL-ARM), Department of Biochemistry & Mole…
ORCID-Profile: Baohua Liu, Ying Ao, Zimei Wang
Förderung
- National Science and Technology Major Project of the Ministry of Science and Technology of China
- National Key R&D Program of China
- National Natural Science Foundation of China
- Program for Youzuzhikeyan of Shenzhen University
- National Key Research and Development Program of China
Zitieren
APA
Ma, C., Jia, J., Lan, J., Wang, J., Rao, D., Rao, L., Zhang, W., Wu, D., Zhang, J., Wang, G., Liu, B., Ao, Y., & Wang, Z. (2026). CK2α Deficiency Drives Myocardial Fibrosis via Desmin‐Induced Mitochondrial Dysfunction. Advanced Science. https://doi.org/10.1002/advs.75560
Vancouver
Ma C, Jia J, Lan J, Wang J, Rao D, Rao L, et al. CK2α Deficiency Drives Myocardial Fibrosis via Desmin‐Induced Mitochondrial Dysfunction. Advanced Science. 2026. doi:10.1002/advs.75560
BibTeX
@article{Ma2026,
author = {Ma, Canjie and Jia, Jiali and Lan, Juncong and Wang, Jing and Rao, Dan and Rao, Lanlan and Zhang, Weibin and Wu, Dongpeng and Zhang, Jie and Wang, Gang and Liu, Baohua and Ao, Ying and Wang, Zimei},
title = {CK2α Deficiency Drives Myocardial Fibrosis via Desmin‐Induced Mitochondrial Dysfunction},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.75560}
}
EUVIMED